Prophylaxis against venous thromboembolism in hospitalized medically ill patients: Update and practical approach.

نویسندگان

  • Ryan Camden
  • Shannon Ludwig
چکیده

PURPOSE Major updates in the medical literature for the prevention of venous thromboembolism (VTE) in medically ill patients are reviewed. A suggested approach for risk assessment is provided along with a brief review of chemical prophylaxis use in special populations of the hospitalized medically ill. SUMMARY Despite new and updated guidelines, the assessment of risk for both thrombosis and bleeding in medical patients continues to lack valid standardization. Pharmacologic prophylaxis with traditional low-dose anticoagulants remains the cornerstone for preventing thrombotic events in this population, but a recent randomized controlled study questioned the clinical impact of this strategy. Currently, there is no gold standard method for determining patient eligibility for pharmacologic prophylaxis for VTE. A suggested approach is to return to the pivotal studies demonstrating benefit to assist in identifying select at-risk patients. However, many populations were under-represented in these studies, including the morbidly obese, patients with chronic kidney disease requiring hemodialysis, and patients with chronic liver disease. Incorporation of evidence for special populations to augment the original studies is required. Until risk-assessment models become validated, along with outcomes data supporting clinical decision-making using such tools, clinician judgment will likely remain the standard of care. CONCLUSION The use of study enrollment criteria and patient demographics, including special population considerations, can provide guidance for risk determination and allow for an evidence-based approach to identifying eligible patients for prophylaxis.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Effects of a Multifaceted Intervention to Improve Venous Thromboembolism Prophylaxis are Sustained Over Time

Background: The majority of venous thromboembolic events occur in hospitalized patients. Although there are several effective regimens, venous thromboembolism (VTE) prophylaxis is still under-utilized in medically-ill patients. In 2003 a multi-faceted quality improvement intervention was implemented to improve the use of VTE prophylaxis. We previously described the significant improvements in V...

متن کامل

Thromboprophylaxis for medical patients with cancer: what do the guidelines say?

Clin. Pract. (2014) 11(2), 155–168 ISSN 2044-9038 part of Venous thromboembolism (VTE) is frequent in cancer patients and is one of the leading causes of death in this population. Hospitalized cancer patients and those receiving chemotherapy are at the greatest risk of developing VTE. Many randomized controlled trials in a variety of patient populations have demonstrated that primary prophylaxi...

متن کامل

Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients.

OBJECTIVE The American College of Chest Physicians (ACCP) recommends unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) for prevention of venous thromboembolism (VTE) in medically ill patients. Despite these recommendations, a previous analysis at our institution revealed a low utilization of VTE prophylaxis in medically ill patients. Our objective was to evaluate the effects o...

متن کامل

Prevention of venous thromboembolism in hospitalized medical patients.

The hospitalized medical patient in the US today has multiple risk factors for venous thromboembolism (VTE) and is therefore at a significant risk of developing this condition both during hospitalization and after discharge. The American College of Chest Physicians (ACCP) guidelines recommend pharmacologic prophylaxis unless there are contraindications. Low-molecular-weight heparins (LMWH) are ...

متن کامل

Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge

BACKGROUND To assess the incidence of venous thromboembolism (VTE) and bleeding events with or without thromboprophylaxis and the associated costs in a cohort of medically ill patients in both in-hospital and outpatient settings. METHODS A large hospital drug database and linked outpatient files were used to identify patients eligible for this analysis, based on demographic and clinical chara...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

دوره 71 11  شماره 

صفحات  -

تاریخ انتشار 2013